GSK To Cut $1.5 Billion In Restructuring Initiative As Avandia Q3 Sales Plummet
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. Avandia sales fall 48 percent to $266 million; overall pharmaceutical sales were down 2 percent to $9.4 billion.